Bernard emphasized strong performances in the QIAstat Diagnostics and QuantiFERON portfolios, with QIAstat achieving 25% CER growth in Q4 and over 660 new system placements in 2024. QuantiFERON grew ...
Q4 2024 Earnings Conference Call February 7, 2025 4:00 AM ET. Company Participants. Merton Kaplan - Head of Investor Relations Micael Johansson - Pres ...